Smithfield Trust
MDCX icon

Smithfield Trust’s Medicus Pharma MDCX Stock Holding History

Smithfield Trust’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
492
+262
+114% +$4.64K ﹤0.01% 896
2026
Q1 		$5K Sell
230
-48
-17% -$2.5K ﹤0.01% 999
2025
Q4 		$21K Buy
+278
New +$29.8K ﹤0.01% 755

Other funds holding MDCX

Interchange Capital Partners
Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
May Hill Capital
May Hill Capital Cohasset, Massachusetts $510M AUM 23.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wilmington Savings Fund Society
Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return

Smithfield Trust's MDCX Position: Q2 2026 in Review

Smithfield Trust increased its Medicus Pharma (MDCX) stake by 114% in Q2 2026, buying an estimated $4.64K and bringing the position to 492 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Smithfield Trust first reported a position in MDCX in Q4 2025 and has held it in 3 quarters since. The position peaked at $21K in Q4 2025. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Smithfield Trust held 492 shares of Medicus Pharma worth $11K as of Q2 2026.
  • Smithfield Trust bought 262 Medicus Pharma shares in Q2 2026, an estimated $4.64K.
  • Medicus Pharma made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #896 holding.
  • Smithfield Trust first reported a position in Medicus Pharma in Q4 2025 and has held it in 3 quarters since.
  • Smithfield Trust's Medicus Pharma position peaked at $21K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.